Cardiology

FDA OKs new anti-clotting drug for heart rhythm disorder

(HealthDay)—A new anti-clotting drug to reduce the risk of dangerous blood clots and strokes in people with a type of heart rhythm disorder has been approved by the U.S. Food and Drug Administration.

Cardiology

Anticoagulation seen in about half of sub-segmental PE cases

(HealthDay)—Sub-segmental pulmonary embolism (SSPE) represents a substantial burden of total pulmonary embolisms (PEs), according to research published online Dec. 1 in the Journal of Thrombosis and Haemostasis.

Diseases, Conditions, Syndromes

Sickle cell trait tied to increased pulmonary embolism risk

(HealthDay)—For African-Americans, sickle cell trait is associated with an increased risk of pulmonary embolism, but not deep vein thrombosis, according to a study published online Nov. 13 in the Journal of Thrombosis and ...

Diseases, Conditions, Syndromes

Thrombosis shouldn't be taken lightly

Venous thromboembolism isn't as well known as stroke or heart attack, but this cardiovascular foe can be just as deadly.

Cardiology

Patient's question triggers important study about blood thinners

Physicians around the world now have guidance that can help them determine the best oral blood thinners to use for their patients suffering from blood clots in their veins, thanks to a patient of The Ottawa Hospital who asked ...

Diseases, Conditions, Syndromes

Glycemic control linked to lumbar surgery complications

(HealthDay)—For patients with diabetes mellitus (DM) undergoing degenerative lumbar spine surgery, suboptimal glycemic control contributes to increased risk of complications and poor outcomes, according to a study published ...

page 21 from 40